Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter of 2023.
- Total net sales for the quarter were $3.2 billion, which is up 3.1% compared to the corresponding period of 2022
- Net income came in at $137 million or $1.05 per share in Q3, vs. $150 million or $1.09 per share in the year-ago quarter
- Adjusted earnings, excluding special items, was $173 million or $1.32 per share, vs. $177 million or $1.29 per share in Q3 2022
- Global Dental sales came in at $1.9 billion in Q3, an increase of 5.4% from the prior-year period
- Global Medical sales moved up 3.1% annually to $1.1 billion during the three-month period
- At $120 million, Global Technology and Value-Added Services sales were up 18.8% year-over-year
- The company invested $417 million in business acquisitions during the third quarter and $668 million year-to-date
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: Key metrics from Estee Lauder’s (EL) Q3 2024 earnings results
The Estee Lauder Companies Inc. (NYSE: EL) reported its third quarter 2024 earnings results today. Net sales were $3.94 billion, up 5% from the prior-year quarter. Organic sales increased 6%.
YUM Earnings: Key quarterly highlights from Yum! Brands’ Q1 2024 financial results
Yum! Brands, Inc. (NYSE: YUM) reported first quarter 2024 earnings results today. Total revenues decreased 3% year-over-year to $1.59 billion. Same-store sales declined 3%. Net income increased 5% to $314
Pfizer (PFE) Q1 2024 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported first quarter 2024 earnings results today. Revenues decreased 20% year-over-year to $14.8 billion. Reported net income declined 44% to $3.1 billion, or $0.55 per share,
